JP2010503674A5 - - Google Patents

Download PDF

Info

Publication number
JP2010503674A5
JP2010503674A5 JP2009528287A JP2009528287A JP2010503674A5 JP 2010503674 A5 JP2010503674 A5 JP 2010503674A5 JP 2009528287 A JP2009528287 A JP 2009528287A JP 2009528287 A JP2009528287 A JP 2009528287A JP 2010503674 A5 JP2010503674 A5 JP 2010503674A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
alkenyl
alkynyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009528287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010503674A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/019905 external-priority patent/WO2008033449A2/en
Publication of JP2010503674A publication Critical patent/JP2010503674A/ja
Publication of JP2010503674A5 publication Critical patent/JP2010503674A5/ja
Withdrawn legal-status Critical Current

Links

JP2009528287A 2006-09-14 2007-09-13 血管形成治療用化合物 Withdrawn JP2010503674A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84455006P 2006-09-14 2006-09-14
PCT/US2007/019905 WO2008033449A2 (en) 2006-09-14 2007-09-13 Compounds for the treatment of angiogenesis

Publications (2)

Publication Number Publication Date
JP2010503674A JP2010503674A (ja) 2010-02-04
JP2010503674A5 true JP2010503674A5 (enExample) 2010-10-21

Family

ID=39092063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009528287A Withdrawn JP2010503674A (ja) 2006-09-14 2007-09-13 血管形成治療用化合物

Country Status (6)

Country Link
US (1) US20100093670A1 (enExample)
EP (1) EP2059250A2 (enExample)
JP (1) JP2010503674A (enExample)
AU (1) AU2007294752A1 (enExample)
CA (1) CA2662554A1 (enExample)
WO (1) WO2008033449A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI252847B (en) 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI332943B (en) 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
US7385084B2 (en) 2004-06-23 2008-06-10 Synta Pharmaceutical Corp. Bis(thio-hydrazide amide) salts for treatment of cancers
EP1877048A1 (en) 2005-04-15 2008-01-16 Synta Pharmaceuticals Corporation Combination cancer therapy with bis(thiohydrazide) amide compounds
TW200735866A (en) * 2005-11-18 2007-10-01 Synta Pharmaceuticals Corp Compounds for the treatment of proliferative disorders
KR20090045354A (ko) 2006-08-21 2009-05-07 신타 파마슈티칼스 코프. 증식성 장애를 치료하기 위한 화합물
WO2008027445A2 (en) 2006-08-31 2008-03-06 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
EP2560652A4 (en) * 2010-04-23 2013-08-14 Kineta Inc ANTIVIRAL CONNECTIONS
WO2015166860A1 (ja) * 2014-04-30 2015-11-05 日本カーバイド工業株式会社 オキシラン化合物及びそれを用いた含窒素複素環式化合物を製造する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101166749B1 (ko) * 2003-02-11 2012-07-27 베르날리스(캠브리지)리미티드 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
TWI339206B (en) * 2003-09-04 2011-03-21 Vertex Pharma Compositions useful as inhibitors of protein kinases
KR100544347B1 (ko) * 2003-12-11 2006-01-23 한국생명공학연구원 디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
NZ560712A (en) * 2005-02-17 2010-12-24 Synta Pharmaceuticals Corp (3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders

Similar Documents

Publication Publication Date Title
JP2008530240A5 (enExample)
US20250230181A1 (en) Pentaaza macrocyclic ring complexes possessing oral bioavailability
JP5610772B2 (ja) 複素環式化合物、それらを含む組成物、及びそれらの使用方法
WO2007070598A8 (en) Nucleotide and oligonucleotide prodrugs
WO2008110585A3 (en) Compositions and methods for preventing and treating mucositis and weight loss
CA2597430A1 (en) Isoxazole combretastin derivatives for the treatment of disorders
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2012054500A3 (en) Compositions for drug administration
JP2009519243A5 (enExample)
NZ702914A (en) Ite for cancer intervention and eradication
MX2009009849A (es) Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.
JP2013537240A5 (enExample)
WO2008000421A3 (en) Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors
WO2008145524A3 (en) 4,4-disubstituted piperidine derivatives
MX2010003914A (es) Nuevas composiciones a base de taxoides.
JP2011518843A5 (enExample)
WO2003031416A3 (en) [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
SK18332002A3 (sk) Farmaceutický prostriedok obsahujúci farmaceuticky prijateľný nosič alebo masťový základ a ako aktívnu prísadu derivát akryloyldistamycínu a inhibítor topoizomerázy I a II
JP2011516551A5 (enExample)
JP2009515996A5 (enExample)
MX2007002531A (es) Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.
JP2007500158A5 (enExample)
JP2019505571A5 (enExample)
WO2007069274A3 (en) Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
HRP20120976T1 (hr) Derivati piridazinona